Pay in 4 interest-free payments of $6.41 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Semaglutide and other GLP-1 drugs can cause side effects like nausea, diarrhoea, dizziness, stomach pain, and constipation
The combination with semaglutide (CagriSema) showed similar tolerability to semaglutide alone
Standard research protocol: BPC-157: 250500mcg per dose TB500: 250500mcg per dose Frequency: once or twice daily Duration: 46 weeks for acute injuries, 812 weeks for chronic conditions Route: subcutaneous or intramuscular injection Acute injury protocol: Higher frequency (twice daily) for the first 12 weeks Localized injections near the injury site are an option Transition to once daily after the early healing phase Total duration: 46 weeks is often enough Chronic condition protocol: Once daily is often enough Systemic (abdominal) injections are common Extended duration (812 weeks) may be needed Cycling on and off is an option for long-term use Post-surgical recovery protocol: Begin immediately after surgery if possible, under medically supervised conditions Twice daily for the first week Once daily for the following 35 weeks Localized injections near the surgical site are an option Dosage Calculator Considerations When calculating precise doses, researchers should consider: Concentration: Standard blend: 10mg BPC-157 + 10mg TB500 per vial Reconstitution volume affects concentration Use PrymaLabs Peptide Calculator for exact figures Example calculation: reconstituting a 10mg+10mg vial with 2mL sterile water: Final concentration: 5mg/mL of each peptide For a 250mcg dose of each: 0.05mL (5 units on an insulin syringe) For a 500mcg dose of each: 0.1mL (10 units on an insulin syringe) Body weight factors: Some research uses weight-based dosing Typical range: 24mcg/kg per peptide Most research uses fixed doses (250500mcg) regardless of weight Adjust based on injury severity and response Reconstitution Protocol Proper reconstitution is essential for preserving peptide stability and ensuring accurate dosing
Where is Found available
Key Research Milestones Timeline Why the History Matters for Researchers Today The research history of GHK-Cu is directly relevant to how researchers should interpret current findings
That's the mechanism behind the "tan," and it's also exactly why the peptide's effects are so unpredictable: you're overriding a hormonal signal, not applying a topical product
![ghk-cu injection sites subcutaneous Product Question] Most effective way to deliver (Copper Tripeptide-1) through skin? : r/SkincareAddiction ghk-cu recommended dosage subcutaneous injection –](https://i.redd.it/wp0jhon6yhmg1.png)
